About Us

Press Release

Contact

Home

Executives

Acquisitions/Mergers

Funding

FDA Updates

Clinical Trials

Pharma

Biotech News

INTEGRA Automated ASSIST PLUS Pipetting Solutions Assist Antibiotic Development

Latest Posts

Lumenis OptiLight Wins 2022 MedTech Breakthrough Award: Best New Technology Solution for Ophthalmology

The win follows Lumenis’ MedTech awards for Best Overall Medical Device Company in 2021 and Best New Surgical Technology Solution in 2020.

The United States Preclinical CRO Market is Projected to Grow at a Compound Annual Growth Rate of 8.87% Between 2022 and 2027

The United States Preclinical CRO Market size was estimated at USD 1,168.70 million in 2021 and expected to reach USD 1,252.61 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.87% to reach USD 1,946.51 million by 202

PharmAust Reports New Australian Clinical Trial to Test a Cancer Drug to Treat Motor Neuron Disease

The Phase 1 trial will test the safety and tolerability of MPL in patients living with MND, and will look for signs that MPL can slow the progression of MND notes PharmAust.

The RSA Group Reports New Study Highlights Talent Needed to Grow the Biosimilars Sector

The RSA Group states the new report features interviews with leaders of biosimilars companies.

INTEGRA is aiding scientists in the vital task of tackling antibiotic resistance by providing the liquid handling tools to help increase throughput and reproducibility in drug development workflows. The company’s ASSIST PLUS pipetting robot, and VIAFLO 96, VIAFLO 384 and MINI 96 handheld electronic pipettes, meet the needs of early phase drug discovery by offering high throughput processing of routine pipetting tasks – such as serial dilutions and plate inoculation – without compromising on precision and reproducibility.

Drug discovery requires large-scale screening to assess the activity of novel compounds against various bacteria. Determining crucial parameters – such as the minimum inhibitory concentration (MIC), IC50, EC50 or LD50 – of candidate antibiotics is an essential step in this process, requiring the generation of multiple serial dilutions and several replicates for every compound. Repetitive pipetting tasks are therefore a common feature in the daily activities of drug discovery labs, and INTEGRA offers a range of time-saving solutions that relieve staff of this burden.

INTEGRA’s ASSIST PLUS can be combined with the company’s VOYAGER adjustable tip spacing pipette to provide an elegant walk-away solution for performing serial dilutions in microplates. This set-up can automate compound transfer and mixing steps – performing them faster and more reliably than manual processing – and allows rapid transfer of compounds or bacterial inoculum from tube formats directly to microplates. Similarly, the VIAFLO 96, VIAFLO 384 or MINI 96 handheld electronic pipettes can be used to perform simultaneous inoculation of every well of a microplate, significantly accelerating assay set-up and eliminating time-associated variability. These innovative pipetting systems, together with other solutions from the INTEGRA portfolio, are helping to alleviate the pipetting bottleneck in antibiotic development, streamlining routine pipetting tasks for more efficient and productive workflows. More here.

Other News

For executives on the move click here.

For all Biotechnology news, click here.

Pharma news can be found here.

For clinical trials and updates, click here.

FDA update news, click here.

For mergers and acquisitions, click here.

For funding, click here.

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine